Detalhe da pesquisa
1.
Essential elements of and challenges to rapid ART implementation: a qualitative study of three programs in the United States.
BMC Infect Dis
; 22(1): 316, 2022 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35361148
2.
Decreased Time From Human Immunodeficiency Virus Diagnosis to Care, Antiretroviral Therapy Initiation, and Virologic Suppression during the Citywide RAPID Initiative in San Francisco.
Clin Infect Dis
; 73(1): e122-e128, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32449916
3.
Rapid Antiretroviral Therapy: Time for a new Standard of Care.
Clin Infect Dis
; 73(1): 134-136, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32777033
4.
The Rapid interaction: a qualitative study of provider approaches to implementing Rapid ART.
Implement Sci Commun
; 4(1): 78, 2023 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37452427
5.
Lessons learned from U.S. rapid antiretroviral therapy initiation programs.
Int J STD AIDS
; 34(13): 945-955, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37461333
6.
Concurrent COVID-19 and Acute HIV: A Case Report and Diagnostic Review.
Case Rep Med
; 2021: 2653678, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34824585
7.
Development of a Citywide Rapid Antiretroviral Therapy Initiative in San Francisco.
Am J Prev Med
; 61(5 Suppl 1): S47-S54, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34686290
8.
A Qualitative Study of the Experience of Immediate Antiretroviral Therapy Among Urban Persons With Newly Diagnosed Human Immunodeficiency Virus.
Open Forum Infect Dis
; 8(12): ofab469, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34877362
9.
RAPID antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population.
AIDS
; 33(5): 825-832, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30882490
10.
Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case report.
Lancet HIV
; 2018 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30503324